DE60114620D1 - Verwendung von cellulosesulfat und andere sulfatierte polysaccharide zu vorbeugung und behandlung von pappiloma-virus-infektionen - Google Patents

Verwendung von cellulosesulfat und andere sulfatierte polysaccharide zu vorbeugung und behandlung von pappiloma-virus-infektionen

Info

Publication number
DE60114620D1
DE60114620D1 DE60114620T DE60114620T DE60114620D1 DE 60114620 D1 DE60114620 D1 DE 60114620D1 DE 60114620 T DE60114620 T DE 60114620T DE 60114620 T DE60114620 T DE 60114620T DE 60114620 D1 DE60114620 D1 DE 60114620D1
Authority
DE
Germany
Prior art keywords
inhibiting
preventing
cellulosesulpate
sulfated polysaccharides
prevention
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60114620T
Other languages
English (en)
Other versions
DE60114620T2 (de
Inventor
C Usher
A Anderson
Lourens J D Zaneveld
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
POLYDEX PHARMACEUTICALS Ltd NASSAU
POLYDEX PHARMA
Rush University Medical Center
Original Assignee
POLYDEX PHARMACEUTICALS Ltd NASSAU
POLYDEX PHARMA
Rush University Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by POLYDEX PHARMACEUTICALS Ltd NASSAU, POLYDEX PHARMA, Rush University Medical Center filed Critical POLYDEX PHARMACEUTICALS Ltd NASSAU
Application granted granted Critical
Publication of DE60114620D1 publication Critical patent/DE60114620D1/de
Publication of DE60114620T2 publication Critical patent/DE60114620T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
DE60114620T 2000-06-30 2001-06-29 Verwendung von Cellulosesulfat und anderen sulfatierten Polysacchariden zur Vorbeugung und Behandlung von Papilloma-Virus-Infektionen Expired - Fee Related DE60114620T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21532500P 2000-06-30 2000-06-30
US215325P 2000-06-30
PCT/CA2001/000964 WO2002002189A2 (en) 2000-06-30 2001-06-29 Cellulose sulfate and other sulfated polysaccharides to prevent and treat papilloma virus infection and other infections

Publications (2)

Publication Number Publication Date
DE60114620D1 true DE60114620D1 (de) 2005-12-08
DE60114620T2 DE60114620T2 (de) 2006-07-27

Family

ID=22802531

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60114620T Expired - Fee Related DE60114620T2 (de) 2000-06-30 2001-06-29 Verwendung von Cellulosesulfat und anderen sulfatierten Polysacchariden zur Vorbeugung und Behandlung von Papilloma-Virus-Infektionen

Country Status (9)

Country Link
US (3) US7078392B2 (de)
EP (1) EP1296691B1 (de)
AT (1) ATE308329T1 (de)
AU (1) AU2001268884A1 (de)
CA (1) CA2414320C (de)
DE (1) DE60114620T2 (de)
DK (1) DK1296691T3 (de)
ES (1) ES2253395T3 (de)
WO (1) WO2002002189A2 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4390259B2 (ja) * 2001-09-06 2009-12-24 有限会社 シーバイオン 硫酸多糖類、その製造方法及びそれを有効成分とする物質
WO2005004882A1 (en) * 2003-07-09 2005-01-20 Monash University Antiviral charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and methods of use thereof
JP2005108098A (ja) * 2003-10-01 2005-04-21 Hitachi Ltd データｉ／ｏ装置及びデータｉ／ｏ装置の制御方法
WO2006066123A1 (en) * 2004-12-17 2006-06-22 Bayer Healthcare Llc Disposable test sensor cartridge
EP1842545A1 (de) * 2006-04-04 2007-10-10 Marinomed Biotechnologie GmbH Entzündungshemmende Polymer
ATE424834T1 (de) * 2006-04-04 2009-03-15 Marinomed Biotechnologie Gmbh Zellulosesulfat zur behandlung von rhinovirus- infektionen
ATE475424T1 (de) * 2006-04-04 2010-08-15 Marinomed Biotechnologie Gmbh Cellulosesulfat zur behandlung von rhinovirus- infektionen
US20100055060A1 (en) * 2006-11-27 2010-03-04 Naoyuki Yoshida Cosmetic composition
US20080131454A1 (en) * 2006-12-05 2008-06-05 Marinomed Biotechnologie Gmbh Methods and Compositions for the Treatment of Rhinovirus Infections with Carrageenan
US20080268022A1 (en) * 2007-02-23 2008-10-30 Mccabe R Tyler Mehtods for treating and preventing ailments caused by human papillomavirus
JP2008266265A (ja) * 2007-04-24 2008-11-06 Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho 抗ウイルス剤
SI2178533T1 (sl) 2007-08-24 2013-07-31 Marinomed Biotechnologie Gmbh Antivirusni sestavek, ki obsega sulfatiran polisaharid: iota-karagenan
US20090118352A1 (en) * 2007-11-07 2009-05-07 Esawtech, Ltd. Broad spectrum microbicidal and spermicidal compositions and methods
US8501214B2 (en) * 2007-11-26 2013-08-06 Modetex Biomedical Materials & Technology Industrial Corp. Hydrophilic foam and pharmaceutical dosage form employing the same
JP5702526B2 (ja) * 2009-04-30 2015-04-15 Ｅｓファイバービジョンズ株式会社 抗ウイルス性を有する硫酸化セルロースを担持させた繊維集合体
TWI401096B (zh) * 2009-12-31 2013-07-11 用以治療、管理或預防陰道感染或子宮頸癌的醫藥劑型及其所包含之膠體組成物與親水性泡綿
MD4110C1 (ro) * 2010-10-21 2011-12-31 Валериу РУДИК Preparat antiherpetiс
FR2989001B1 (fr) 2012-04-06 2017-07-21 Centre Nat Rech Scient Microparticules et nanoparticules constituees de polysaccharides hydrophobises et d'une alpha-cyclodextrine
FR2998176B1 (fr) * 2012-11-16 2015-01-16 Univ Blaise Pascal Clermont Ii Composition de polysaccharide sulfate
WO2014147287A1 (en) 2013-03-21 2014-09-25 Jukka Seppälä Nanocrystalline cellulose (ncc) as an antiviral compound
EP3204016B1 (de) 2014-10-06 2021-08-25 Algamed Therapeutics (A.M.T) Ltd. Zusammensetzungen mit sulfatierten polysacchariden und verwendungen davon
CN105748506B (zh) * 2016-03-03 2018-08-17 青岛海洋生物医药研究院股份有限公司 褐藻酸硫酸酯在制备预防和治疗由人乳头瘤状病毒引起的疾病的药物和保健品中的应用
EP3939597A1 (de) * 2020-07-16 2022-01-19 Marinomed Biotech AG Antivirale pharmazeutische zusammensetzung enthaltend carrageenan

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL70511A (en) 1982-12-28 1990-01-18 Anic Spa Process for the concurrent depolymerization and sulfation of polysaccharides at hydroxyl groups
FR2542616B1 (fr) * 1983-03-17 1987-07-31 Unilever Nv Composition pour le traitement des muqueuses a base d'un antibiotique et d'un hydrocolloide formateur de gel
EP0240098A3 (de) 1986-04-04 1989-05-10 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Oligo und Polysaccharide zur Behandlung von Krankheiten verursacht durch Retroviren
EP0298706B1 (de) 1987-07-07 1994-09-07 Ajinomoto Co., Inc. Verwendung von Glycanen als antivirale Verbindungen.
EP0402078A3 (de) * 1989-06-06 1991-07-31 Patrick Daniel Kelly Sexuelles Gleitmittel mit Zink als antiviralem Wirkstoff
US5208031A (en) * 1989-06-06 1993-05-04 Kelly Patrick D Sexual lubricants containing zinc as an anti-viral agent
AU1052492A (en) 1991-01-31 1992-08-06 Farmitalia Carlo Erba S.R.L. Synergistic composition comprising a fibroblast growth factor and a sulfated polylsaccharide, for use as antiviral agent
KR950703336A (ko) * 1992-10-13 1995-09-20 가츠히로 도미타 악액질의 치료와 il-6 활성의 저해
US5780452A (en) * 1993-09-20 1998-07-14 Ajinomoto Co., Inc. Antimalarial drug
US6063773A (en) 1995-09-29 2000-05-16 Polydex Pharmaceuticals Ltd. Cellulose sulfate for use as antimicrobial and contraceptive agent
US6239182B1 (en) 1995-10-13 2001-05-29 Rush-Presbyterian-St. Lukes Medical Center Method for preventing sexually transmitted diseases
US5741525A (en) 1995-10-24 1998-04-21 Marshall University Research Corporation Vaginal pharmaceutical hydrogen peroxide composition
US5955096A (en) * 1996-06-25 1999-09-21 Brown University Research Foundation Methods and compositions for enhancing the bioadhesive properties of polymers using organic excipients
US5853767A (en) 1997-01-02 1998-12-29 Melman; Steven A. Compositions for treating fungal, parasitic and/or bacterial infections, especially infections of organs such as the skin and vagina
JPH1180003A (ja) * 1997-09-16 1999-03-23 Yakult Honsha Co Ltd 感染症予防・治療剤

Also Published As

Publication number Publication date
US20050143342A1 (en) 2005-06-30
US7078392B2 (en) 2006-07-18
WO2002002189A2 (en) 2002-01-10
CA2414320C (en) 2008-04-01
US7226914B2 (en) 2007-06-05
ATE308329T1 (de) 2005-11-15
WO2002002189A3 (en) 2002-09-19
US20050203055A1 (en) 2005-09-15
US20030181415A1 (en) 2003-09-25
ES2253395T3 (es) 2006-06-01
US7235536B2 (en) 2007-06-26
DK1296691T3 (da) 2006-03-20
AU2001268884A1 (en) 2002-01-14
CA2414320A1 (en) 2002-01-10
DE60114620T2 (de) 2006-07-27
EP1296691B1 (de) 2005-11-02
EP1296691A2 (de) 2003-04-02

Similar Documents

Publication Publication Date Title
DE60114620D1 (de) Verwendung von cellulosesulfat und andere sulfatierte polysaccharide zu vorbeugung und behandlung von pappiloma-virus-infektionen
BR0109165A (pt) Método de tratamento de pólipos colÈnicos
NO20026044L (no) Behandling av humant papillomavirus
ATE508735T1 (de) Pulmonale verabreichung von aminoglykosiden
DE60124684D1 (de) Sulfonamido-substituierte verbrückte bicycloalkylderivative
BR0116519B1 (pt) cartucho de hemodiafiltraÇço/hemofiltraÇço de diluiÇço intermediÁria.
DE69913020D1 (de) Transparente Antischuppen-Haarwaschzusammensetzungen
ATE335499T1 (de) Zusammensetzungen zur behandlung von staphylococcus aureus infektionen
AU2002359450A1 (en) Compositions and methods for removal of incidental soils from fabric articles via soil modification
ATE245444T1 (de) Pharmazeutische zusammensetzung, enthaltend peg- asparaginase, für die behandlung von hiv infektionen
ATE517617T1 (de) Behandlung von parkinson erkrankung mit kape
NO20032406D0 (no) Anvendelse av 1-fenyl-3-dimetylaminopropanforbindelser for behandling av urininkontinens
ATE493113T1 (de) Topische zubereitung zur behandlung von zehennagelpilz
DE60030300D1 (de) Topische behandlung zur vorbeugung von augeninfektionen
DE60142786D1 (de) Zusammensetzungen und methoden zur behandlung von candidosen
DE60204967D1 (de) Verwendung von übersulfatierten polysacchariden als hiv-hemmer
ATE408340T1 (de) Prävention und behandlung von mycoplasma- assoziierten krankheiten mit trans-sialidase und/oder neuraminidase
BR0010699A (pt) Benzimidazóis substituìdos, sua produção e utilização dos mesmos como agente contra protozoários parasitários
NO20030137L (no) Fremgangsmåte for behandling av ustabil angina pectoris
DE60237821D1 (de) Antibakterielle behandlung von osteoarthritis
DE60336063D1 (de) Verfahren, zusammensetzung und kit für die antigenbindung von norwalk-ähnlichen viren
DE60125035D1 (de) Behandlung von plasmid-haltigen lösungen
FR2811572B1 (fr) Utilisation de cyclodextrines polysulfatees pour le traitement de l'arthrose
TR200003084T2 (tr) Paroxetine askorbat
DE60127703D1 (de) Verwendung von xestospongin c zur behandlung oder vorbeugung einer hiv-infektion

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee